NEWS

Sim&Cure Announces U.S. FDA 510(k) Clearance for Sim&Size software

Montpellier – Sim&Cure is honored and proud to announce last September 17, Sim&Size® obtained U.S.Food and Drug Administration (FDA) 510(k) clearance.

StrokEnomics - the economic value of stroke treatments

An expert advice on the realities of stroke treatment

Phenox Announces Exclusive Distribution Agreement with Wallaby Medical I...

Phenox is pleased to announce that it has signed an exclusive distribution agreement with Wallaby Medical Inc. for commercialization of The Avenir™ Detachable Coil System in the U.S. and EU markets.

Wallaby Medical Inc. announces CE Mark and FDA Clearance of the Avenir™...

Wallaby Medical announces CE Mark approval and FDA 510(k) clearance of its differentiated embolic coil system, the Avenir Coil System. The intended use for the Avenir Coil System is for endovascular embolization of intracranial aneurysms and other neurovascular abnormalities such as arteriovenous malformations and arteriovenous fistulae. The Avenir Coil System is also intended for arterial and venous embolization in the peripheral vasculature.

A rare and surprising cause of cervical myelopathy

Mechanical Thrombectomy in distal MCA occlusion

Endovascular treatment of the superior cerebellar artery

1st Pass Success with NeVa™ "M1S" (4.0 x 22 mm) after failure of 2 diffe...

Watch this clinical case report from a 75 year old female patient presented with NIHSS of 19 presented 4 hours after symptom onset.It was noted that the patient had had a knee implant surgery 3 days prior to her stroke. Additional risk factors included: Coronary Heart Failure, Hypertension, Diabetes, Atrial fibrillation.On admission CT ASPECTS was 10.Imaging confirmed distal left MCA occlusion.

Ruptured Brain Stem AVM Causing vessel Perforation